The Trump administration's first mandatory CMS pay model is projected to save taxpayers and patients $17.2 billion over five years by shifting Medicare Part B drugs to price levels more closely aligned with what other countries pay.
The FDA's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can reduce severity and shorten duration of flu symptoms after one just dose.
The CMS and drug companies have different ideas on what kind of price information consumers should have and how they should access it.
The American Medical Association and RAND Corp. release findings from a study assessing how physicians view new pay models. Also this week, earnings season continues.
The CMS released a proposed rule that would require drugmakers to list prices for their drugs in their consumer advertising.
Five doctors, a pharmacist and three medical assistants were among 10 defendants charged with taking in more than $5 million by illegally prescribing millions of oxycodone pills to patients, including apparent drug addicts, who had no legitimate medical need for them.
Sixteen months after Walgreens Boots Alliance concluded a disastrous relationship with Theranos, the now-defunct Silicon Valley blood-testing company, the pharmacy giant has linked up with LabCorp, one of the world's largest clinical laboratory operators.
U.S. regulators Friday expanded the use of Merck's cervical cancer vaccine to adults up to age 45.
Wholesale drug distributor AmerisourceBergen agreed to pay federal and state governments $625 million for illegally distributing misbranded drugs, including pre-filled cancer syringes.
Gilead Sciences' move to launch generic versions of two hepatitis C treatments could motivate states to eliminate restrictions on their Medicaid and inmate populations.
An analysis of brand-name prescription drug prices shows it's been business as usual for drugmakers, with far more price hikes than cuts. The number of increases slowed somewhat and were not quite as steep as in past years.
Instagram has begun using some drug-related hashtags, such as “opioid” and “uppers,” to steer users of the app to information about opioid treatment and recovery.